Photocure ASA
OSE:PHO

Watchlist Manager
Photocure ASA Logo
Photocure ASA
OSE:PHO
Watchlist
Price: 48.7 NOK -3.56% Market Closed
Market Cap: 1.3B NOK
Have any thoughts about
Photocure ASA?
Write Note

Photocure ASA
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Photocure ASA
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Photocure ASA
OSE:PHO
Cash from Operating Activities
kr56.2m
CAGR 3-Years
62%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
V
Vistin Pharma ASA
OSE:VISTN
Cash from Operating Activities
kr62.4m
CAGR 3-Years
10%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
N
Navamedic ASA
OSE:NAVA
Cash from Operating Activities
kr5.6m
CAGR 3-Years
49%
CAGR 5-Years
1%
CAGR 10-Years
N/A
S
SoftOx Solutions AS
OSE:SOFTX
Cash from Operating Activities
-kr2.5m
CAGR 3-Years
65%
CAGR 5-Years
30%
CAGR 10-Years
N/A
No Stocks Found

Photocure ASA
Glance View

Market Cap
1.3B NOK
Industry
Pharmaceuticals

Photocure ASA delivers transformative solutions to improve the lives of bladder cancer patients. The company is headquartered in Oslo, Oslo. The company went IPO on 2000-05-29. The company operates in the field of photodynamic diagnosis, cosmetics and treatment of acne, bladder cancer, colon cancer, as well as human papilloma virus (HPV) and precancerous lesions of the cervix. The Company’s activities comprise research, development and commercialization of pipeline projects within two segments: Cancer and Dermatology. Its brand portfolio includes: Hexvix and Cysview, for detection and management of bladder cancer; Visonac, for acne treatment; Cevira, used in HPV and precancerous lesions of the cervix treatment; and Lumacan, applied in colorectal cancer treatment. Furthermore, It owns a Photocure Technology platform, which develops photodynamic technology for diagnosis and therapy. The firm is a parent of a wholly owned entity, Photocure Inc.

PHO Intrinsic Value
69.23 NOK
Undervaluation 30%
Intrinsic Value
Price

See Also

What is Photocure ASA's Cash from Operating Activities?
Cash from Operating Activities
56.2m NOK

Based on the financial report for Jun 30, 2024, Photocure ASA's Cash from Operating Activities amounts to 56.2m NOK.

What is Photocure ASA's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 3Y
62%

Over the last year, the Cash from Operating Activities growth was 34%. The average annual Cash from Operating Activities growth rates for Photocure ASA have been 62% over the past three years .

Back to Top